
Fluidigm Corporation FLDM
Fluidigm Corporation Gesamtverbindlichkeiten | FLDM
Gesamtverbindlichkeiten Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 186 M | 111 M | 232 M | 256 M | 253 M | 256 M | 257 M | 20.5 M | 13.1 M | 22.4 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 257 M | 13.1 M | 161 M |
Gesamtverbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | ||
|
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 257.93 | 1.18 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
31.8 B | $ 230.45 | 1.76 % | $ 164 B | ||
|
IDEXX Laboratories
IDXX
|
1.75 B | $ 676.3 | 0.83 % | $ 54.4 B | ||
|
Illumina
ILMN
|
2.7 B | $ 213.05 | 2.43 % | $ 33 B | ||
|
Lantheus Holdings
LNTH
|
1.14 B | $ 100.61 | -0.09 % | $ 6.79 B | ||
|
Accelerate Diagnostics
AXDX
|
84.6 M | - | -61.36 % | $ 2.46 M | ||
|
Medpace Holdings
MEDP
|
1.52 B | $ 653.24 | 2.88 % | $ 18.8 B | ||
|
Mettler-Toledo International
MTD
|
3.74 B | $ 1 722.36 | 2.64 % | $ 35.5 B | ||
|
Natera
NTRA
|
686 M | $ 319.38 | -12.2 % | $ 43.7 B | ||
|
Charles River Laboratories International
CRL
|
3.92 B | $ 338.13 | 8.07 % | $ 16.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
16 B | $ 30.33 | -0.57 % | $ 28.8 B | ||
|
QIAGEN N.V.
QGEN
|
3.11 B | $ 50.36 | -0.98 % | $ 10.9 B | ||
|
RadNet
RDNT
|
2.4 B | $ 75.83 | -2.79 % | $ 5.7 B | ||
|
Senseonics Holdings
SENS
|
65.2 M | $ 8.58 | 7.38 % | $ 358 M | ||
|
T2 Biosystems
TTOO
|
62.8 M | - | -39.35 % | $ 313 K | ||
|
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | ||
|
Neuronetics
STIM
|
115 M | $ 2.17 | -10.91 % | $ 143 M | ||
|
Thermo Fisher Scientific
TMO
|
28.7 B | $ 694.85 | 2.62 % | $ 262 B | ||
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M | ||
|
Trinity Biotech plc
TRIB
|
138 M | $ 6.07 | 2.97 % | $ 2.18 B | ||
|
Brainsway Ltd.
BWAY
|
14.4 M | $ 11.12 | 4.81 % | $ 378 M | ||
|
VolitionRx Limited
VNRX
|
42.5 M | $ 0.2 | 3.39 % | $ 25.2 M | ||
|
Waters Corporation
WAT
|
2.52 B | $ 458.04 | 1.06 % | $ 27.3 B | ||
|
Exagen
XGN
|
40.6 M | $ 5.79 | -23.82 % | $ 125 M | ||
|
Guardant Health
GH
|
2.11 B | $ 151.28 | -1.4 % | $ 19 B | ||
|
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 366.98 | 1.02 % | $ 30.5 B | ||
|
IQVIA Holdings
IQV
|
23.3 B | $ 271.72 | 2.59 % | $ 46.7 B | ||
|
Quotient Limited
QTNT
|
338 M | - | -11.32 % | $ 1.1 M | ||
|
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
59.7 M | - | - | $ 608 M | ||
|
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | ||
|
Syneos Health
SYNH
|
4.7 B | - | - | $ 4.46 B | ||
|
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | ||
|
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | ||
|
Renalytix AI plc
RNLX
|
15.8 M | - | 5.66 % | $ 22.7 M | ||
|
Psychemedics Corporation
PMD
|
3.19 M | - | -1.84 % | $ 15.3 M | ||
|
Meridian Bioscience
VIVO
|
135 M | - | - | $ 1.49 B | ||
|
Celcuity
CELC
|
366 M | $ 66.73 | 3.9 % | $ 3.12 B | ||
|
DexCom
DXCM
|
3.59 B | $ 79.42 | -5.97 % | $ 31 B | ||
|
Agilent Technologies
A
|
5.99 B | $ 175.14 | 1.97 % | $ 49.7 B | ||
|
Castle Biosciences
CSTL
|
108 M | $ 32.49 | -4.99 % | $ 942 M | ||
|
Anixa Biosciences
ANIX
|
2.13 M | $ 3.16 | 4.29 % | $ 103 K | ||
|
Biodesix
BDSX
|
89.9 M | $ 8.51 | -57.13 % | $ 64.3 M | ||
|
BioNano Genomics
BNGO
|
29.2 M | $ 1.15 | 4.54 % | $ 6.26 M | ||
|
Bioventus
BVS
|
455 M | $ 10.61 | -0.66 % | $ 707 M | ||
|
Fulgent Genetics
FLGT
|
107 M | $ 23.68 | 26.9 % | $ 729 M | ||
|
CareDx, Inc
CDNA
|
110 M | $ 78.47 | 2.8 % | $ 4.18 B |